Search Results - "SANNERUD, C. A"

Refine Results
  1. 1

    Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal by Griffiths, R R, Sannerud, C A, Ator, N A, Brady, J V

    “…This study examined in baboons various behavioral effects of zolpidem, a short-acting imidazopyridine hypnotic which has selectivity for subtypes of the…”
    Get more information
    Journal Article
  2. 2

    Absorption rate of methylxanthines following capsules, cola and chocolate by MUMFORD, G. K, BENOWITZ, N. L, EVANS, S. M, KAMINSKI, B. J, PRESON, K. L, SANNERUD, C. A, SILVERMAN, K, GRIFFITHS, R. R

    “…To compare caffeine and theobromine absorption after oral administration of capsules, cola beverage and chocolate candy. Three males and four females who…”
    Get full text
    Journal Article
  3. 3

    Low-dose caffeine physical dependence in humans by Griffiths, R R, Evans, S M, Heishman, S J, Preston, K L, Sannerud, C A, Wolf, B, Woodson, P P

    “…This study investigated the effects of terminating low dose levels of caffeine (100 mg/day) in 7 normal humans. Substitution of placebo capsules for caffeine…”
    Get more information
    Journal Article
  4. 4

    Drug discrimination analysis of midazolam under a three-lever procedure. II: Differential effects of benzodiazepine receptor agonists by Sannerud, C A, Ator, N A

    “…Twelve rats were trained to discriminate 0.32 and 3.2 mg/kg s.c. midazolam from no drug under a three-lever, multiple trials drug discrimination procedure. In…”
    Get more information
    Journal Article
  5. 5

    Drug discrimination analysis of midazolam under a three-lever procedure: I. Dose-dependent differences in generalization and antagonism by Sannerud, C A, Ator, N A

    “…Twelve rats were trained to discriminate two doses of midazolam, 0.32 and 3.2 mg/kg, from no drug under a three-lever, multiple-trials procedure (15-min…”
    Get more information
    Journal Article
  6. 6

    Low-dose caffeine discrimination in humans by Griffiths, R R, Evans, S M, Heishman, S J, Preston, K L, Sannerud, C A, Wolf, B, Woodson, P P

    “…A novel drug discrimination procedure was used to study the discriminability and subjective effects of caffeine in seven human volunteers who abstained from…”
    Get more information
    Journal Article
  7. 7

    Physical dependence in baboons chronically treated with low and high doses of diazepam by Kaminski, B J, Sannerud, C A, Weerts, E M, Lamb, R J, Griffiths, R R

    Published in Behavioural pharmacology (01-07-2003)
    “…Physical dependence on diazepam was evaluated in male baboons chronically treated with either low or high doses of diazepam. Baboons received either a single…”
    Get full text
    Journal Article
  8. 8

    Discriminative stimulus and subjective effects of theobromine and caffeine in humans by MUMFORD, G. K, EVANS, S. M, KAMINSKI, B. J, PRESTON, K. L, SANNERUD, C. A, SILVERMAN, K, GRIFFITHS, R. R

    Published in Psychopharmacologia (01-06-1994)
    “…Theobromine versus placebo discrimination and caffeine versus placebo discrimination were studied in two consecutive experiments in seven volunteers who…”
    Get full text
    Journal Article
  9. 9

    Tolerance to the behavioral effects of chlordiazepoxide: pharmacological and biochemical selectivity by Sannerud, C A, Marley, R J, Serdikoff, S L, Alastra, A J, Cohen, C, Goldberg, S R

    “…There is a dynamic interaction between a drug's pharmacological effects and the behavioral context in which it is administered. The present study evaluated the…”
    Get more information
    Journal Article
  10. 10

    Self-injection of barbiturates, benzodiazepines and other sedative-anxiolytics in baboons by GRIFFITHS, R. R, LAMB, R. J, SANNERUD, C. A, ATOR, N. A, BRADY, J. V

    Published in Psychopharmacologia (01-02-1991)
    “…Self-injection of 12 sedative-anxiolytics was examined in baboons. Intravenous injections and initiation of a 3-h time-out were dependent upon completion of a…”
    Get full text
    Journal Article
  11. 11

    The effects of sertraline on nicotine self-administration and food-maintained responding in squirrel monkeys by Sannerud, C A, Prada, J, Goldberg, D M, Goldberg, S R

    Published in European journal of pharmacology (27-12-1994)
    “…Recent reports suggested the involvement of serotonergic mechanisms in nicotine self-administration. The present study assessed the effects of sertraline, a…”
    Get more information
    Journal Article
  12. 12

    Environmental modification of tolerance to morphine discriminative stimulus properties in rats by SANNERUD, C. A, YOUNG, A. M

    Published in Psychopharmacologia (01-01-1987)
    “…The development of tolerance to the discriminative stimulus properties of morphine was examined in rats trained to discriminate saline and 3.2 mg/kg morphine…”
    Get full text
    Journal Article
  13. 13

    Behavioral pharmacology of tandospirone in baboons: chronic administration and withdrawal, self-injection and drug discrimination by Sannerud, C A, Ator, N A, Griffiths, R R

    Published in Drug and alcohol dependence (01-05-1993)
    “…The behavioral pharmacology of tandospirone (SM 3997), a novel anxiolytic/antidepressant pyrimidinylpiperazine compound with selective pharmacological effects…”
    Get more information
    Journal Article
  14. 14

    Modification of morphine tolerance by behavioral variables by Sannerud, C A, Young, A M

    “…These experiments assessed whether the opportunity to perform a target operant in the presence of morphine would alter the development of behavioral tolerance…”
    Get more information
    Journal Article
  15. 15

    The stimulus properties of two common over-the-counter drug mixtures: dextromethorphan + ephedrine and dextromethorphan + diphenhydramine by Gauvin, D V, Vanecek, S A, Baird, T J, Vallett, M, Briscoe, R J, Carl, K L, Holloway, F A, Sannerud, C A

    “…Two groups of rats were trained in a two-choice drug discrimination procedure under a fixed-ratio 10 schedule of food reinforcement. One group of rats (n=12)…”
    Get more information
    Journal Article
  16. 16

    Intravenous self-administration of 4-methylaminorex in primates by Mansbach, R S, Sannerud, C A, Griffiths, R R, Balster, R L, Harris, L S

    Published in Drug and alcohol dependence (01-10-1990)
    “…The reinforcing effects of (+/-)-cis-2-Amino-4-methyl-5-phenyl-2-oxazoline (4-methylaminorex) were determined in two models of intravenous drug…”
    Get more information
    Journal Article
  17. 17

    Behavioral differentiation of benzodiazepine ligands after repeated administration in baboons by Sannerud, C A, Cook, J M, Griffiths, R R

    Published in European journal of pharmacology (29-08-1989)
    “…Baboons received repeated daily administration of saline, 5.6 mg/kg midazolam, 5.0 mg/kg flumazenil (Ro15-1788), 3.2 mg/kg 3-carboethoxy-beta-carboline…”
    Get more information
    Journal Article
  18. 18

    Comparison of the discriminative stimulus effects of midazolam after intracranial and peripheral administration in the rat by Sannerud, C A, Ator, N A, Griffiths, R R

    Published in Life sciences (1973) (1991)
    “…Rats were trained in a two-lever drug discrimination paradigm to discriminate midazolam (0.32 mg/kg, i.p. or 1.0 mg/kg, i.p.) from the no-drug condition. After…”
    Get more information
    Journal Article
  19. 19

    Amantadine: evaluation of reinforcing properties and effect on cocaine self-injection in baboons by Sannerud, C A, Griffiths, R R

    Published in Drug and alcohol dependence (01-07-1988)
    “…The ability of amantadine to maintain self-injection behavior and to alter self-administration of cocaine was examined in baboons using a standard intravenous…”
    Get more information
    Journal Article
  20. 20

    General activity in baboons measured with a computerized, lightweight piezoelectric motion sensor: effects of drugs by Hienz, R D, Turkkan, J S, Spear, D J, Sannerud, C A, Kaminski, B J, Allen, R P

    Published in Pharmacology, biochemistry and behavior (01-07-1992)
    “…A small, 1-oz activity-monitoring device is described for measuring motor activity continuously for periods of up to 42 days. The monitor employs a…”
    Get more information
    Journal Article